Stay updated on Darolutamide in Addition to ADT Clinical Trial
Sign up to get notified when there's something new on the Darolutamide in Addition to ADT Clinical Trial page.

Latest updates to the Darolutamide in Addition to ADT Clinical Trial page
- Check8 days agoChange DetectedFooter revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check15 days agoChange DetectedThe record shows the trial status updated to Completed on 2026-02-27, replacing the previous Active, not recruiting status, and adding new Contacts/Locations, Study Status, and Recruitment Status sections on 2026-02-09.SummaryDifference0.3%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe References section was removed from the study record page, and the list of cited sources is no longer displayed.SummaryDifference0.0%

- Check36 days agoChange DetectedA new history entry on 2026-02-06 adds a Study Status update with Revision: v3.4.2. The prior government funding notice (2026-01-14) has been removed (Revision: v3.4.1).SummaryDifference0.6%

- Check43 days agoChange DetectedThe page now displays a general government-funding notice and updates the site software revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check50 days agoChange DetectedAdded a glossary toggle and color-coded change indicators to explain edits in the record history. Revision notes now show 'No FEAR Act Data' and 'Revision: v3.4.0' with the previous 'Revision: v3.3.4' entry removed.SummaryDifference0.5%

Stay in the know with updates to Darolutamide in Addition to ADT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Darolutamide in Addition to ADT Clinical Trial page.